Skip to Content

Spritam Approval History

  • FDA approved: Yes (First approved August 3rd, 2015)
  • Brand name: Spritam
  • Generic name: levetiracetam
  • Dosage form: Tablets
  • Company: Aprecia Pharmaceuticals Company
  • Treatment for: Seizures, Epilepsy

Spritam (levetiracetam) is a 3D printed drug product used as adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy.

Development History and FDA Approval Process for Spritam

Aug  3, 2015Approval FDA Approves Spritam (levetiracetam) as the First 3D Printed Drug Product

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.